Acciones Lexagene Holdings Inc Toronto S.E.
Acciones
WEY
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-41,97 % | 7921,86 M | |
+5,99 % | 3508,33 M | |
-4,31 % | 2177,1 M | |
-21,69 % | 1968,27 M | |
-24,94 % | 1578,65 M | |
+31,45 % | 1143,67 M | |
+26,75 % | 792 M | |
-9,83 % | 690 M | |
-26,33 % | 532 M |